中山大学，简称中大，是一所中国大陆的综合性研究型大学，位于广东省广州市、珠海市和深圳市，直属于中华人民共和国教育部，由教育部与广东省人民政府共建。 中山大学前身为孙中山于1924年创立的国立广东大学，1926年为纪念孙中山改称国立中山大学。

During the past decade, Sun Yat-sen University conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sun Yat-sen University" #1 sponsor was "Sun Yat-sen University" with 43 trials, followed by "Huilian Zhu" with 3 trials sponsored, "Min Xia" with 2 trials sponsored, "Shenzhen Hornetcorn Bio-technology Company, LTD" with 2 trials sponsored and "Shi Yanxia" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sun Yat-sen University" #1 collaborator was "Sun Yat-sen University" with 5 trials as a collaborator, "Fifth Affiliated Hospital of Guangzhou Medical University" with 2 trials as a collaborator, "West China Hospital" with 2 trials as a collaborator, "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 1 trials as a collaborator and "Affiliated Cancer Hospital of Shantou University Medical College" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Sun Yat-sen University" are "Healthy" (4 trials), "Nasopharyngeal Carcinoma" (4 trials), "Surgery" (4 trials), "Non-small Cell Lung Cancer" (3 trials) and "Pain" (3 trials). Many other conditions were trialed in "Sun Yat-sen University" in a lesser frequency.

Most popular intervention types in "Sun Yat-sen University" are "Drug" (33 trials), "Other" (14 trials), "Dietary Supplement" (8 trials), "Radiation" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Conserved therapy" (2 trials), "Flurbiprofen Axetil" (2 trials), "Highland barley β-glucan dietary supplement" (2 trials) and "Human umbilical cord mesenchymal stem cells" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sun Yat-sen University" are 62 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sun Yat-sen University". 1 are not yet recruiting, 22 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Sun Yat-sen University, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sun Yat-sen University, 8 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 20 trials that are defined as “Not Applicable".

Sun Yat-sen University has several departments that took part in Clinical trials: "Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University" - 8 trials, "Department of colorectal surgery, the Sixth Affiliated Hospital, Sun Yat-Sen University" - 8 trials, "State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center" - 5 trials, "Department of Nephrology, 6th Affiliated Hospital, Sun Yat-Sen University" - 5 trials, "Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-Sen University (Northern Campus)" - 4 trials, "Urology Department, Sun Yet-Sen University Cancer Center" - 2 trials